AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Di Leo L, Pagliuca C, Kishk A, Rizza S, et al. Proc Natl Acad Sci U S A 2024;121:e2400566121.

Read + Share

Amedeo Smart

Independent Medical Education

Di Leo L, Pagliuca C, Kishk A, Rizza S, et al. AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proc Natl Acad Sci U S A 2024;121:e2400566121.
PMID: 38870061